| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Terns Pharma (NASDAQ:TERN) reported its Q1 earnings results on Monday, May 16, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Terns Pharma beat estimated earnings by 14.06%, reporting an EPS of $-0.55 versus an estimate of $-0.64.
Revenue was down $0.00 from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 5.77% increase in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for Terns Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: TERN
